BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30111490)

  • 1. HPV-related cancers-we can prevent them and we should.
    Feldman S
    Curr Probl Cancer; 2018 Sep; 42(5):456. PubMed ID: 30111490
    [No Abstract]   [Full Text] [Related]  

  • 2. HPV vaccination and the effects on rates of HPV-related cancers.
    St Laurent J; Luckett R; Feldman S
    Curr Probl Cancer; 2018 Sep; 42(5):493-506. PubMed ID: 30041818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer.
    Shibata T; Lieblong BJ; Sasagawa T; Nakagawa M
    Cancer Treat Rev; 2019 Aug; 78():8-16. PubMed ID: 31302573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus infection and related cancers in sub-Saharan Africa: burden and tools for prevention.
    Awolude OA; Morhason-Bello IO; Denny LA; Adewole IF
    Vaccine; 2013 Dec; 31 Suppl 5():vii-x. PubMed ID: 24331751
    [No Abstract]   [Full Text] [Related]  

  • 5. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
    Michelow P; Firnhaber C
    Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
    [No Abstract]   [Full Text] [Related]  

  • 6. Human papillomavirus.
    Highleyman L
    BETA; 2007; 19(4):35-9. PubMed ID: 18069155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Approaches for Vaccination Against HPV-Induced Cancers.
    King E; Ottensmeier C; Pollock KGJ
    Curr Top Microbiol Immunol; 2017; 405():33-53. PubMed ID: 25735921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV vaccine update: new indications and controversies.
    Mendoza N; Hernandez PO; Tyring SK
    Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human papillomavirus nonavalent vaccine. Update 2017].
    Bosch FX; Moreno D; Redondo E; Torné A
    Semergen; 2017; 43(4):265-276. PubMed ID: 28549940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
    Khaliq SA; Shyum Naqvi SB; Fatima A
    Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report.
    de Sanjosé S; Serrano B; Castellsagué X; Brotons M; Muñoz J; Bruni L; Bosch FX
    Vaccine; 2012 Nov; 30 Suppl 4():D1-83, vi. PubMed ID: 23510764
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigational 9-valent HPV vaccine could prevent almost 90% of cervical cancers.
    Hum Vaccin Immunother; 2014; 10(11):3105-6. PubMed ID: 25789368
    [No Abstract]   [Full Text] [Related]  

  • 13. School nurses' attitudes towards and experiences of the Swedish school-based HPV vaccination programme - A repeated cross sectional study.
    Grandahl M; Larsson M; Tydén T; Stenhammar C
    PLoS One; 2017; 12(4):e0175883. PubMed ID: 28419156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in eliminating HPV-associated disease.
    Stern PL; Canfell K
    Papillomavirus Res; 2019 Dec; 8():100180. PubMed ID: 31425856
    [No Abstract]   [Full Text] [Related]  

  • 15. Human papillomavirus vaccines six years after approval.
    Shaw AR
    Annu Rev Med; 2013; 64():91-100. PubMed ID: 23190152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policies.
    Lehtinen M; Baussano I; Paavonen J; Vänskä S; Dillner J
    Expert Rev Vaccines; 2019 Feb; 18(2):153-160. PubMed ID: 30657348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of papillomavirus-related cancers through immunization.
    Frazer IH; Leggatt GR; Mattarollo SR
    Annu Rev Immunol; 2011; 29():111-38. PubMed ID: 21166538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting the immunization neighborhood: Benefits and challenges of pharmacies as additional locations for HPV vaccination.
    Rothholz M; Tan LLJ
    Hum Vaccin Immunother; 2017 Aug; 13(8):1856-1858. PubMed ID: 27216035
    [No Abstract]   [Full Text] [Related]  

  • 19. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
    Han JJ; Tarney CM; Song J
    Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway.
    Hansen BT; Campbell S; Nygård M
    BMJ Open; 2018 Feb; 8(2):e019005. PubMed ID: 29476028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.